logo
The 2025 measles outbreak is largest in three decades

The 2025 measles outbreak is largest in three decades

Politico09-07-2025
Kennedy has pointed to the much higher measles rates and death toll in Europe in arguing that the U.S. response to the outbreak 'is a model for the rest of the world.' He's asked the CDC to develop new guidance for treating the disease.
'People should be getting healthier. We've got more solutions. Medicine is advancing, and yet you're seeing people turning away from it,' said Dr. Amesh Adalja, an expert on infectious disease and senior scholar at the Johns Hopkins Center for Health Security. 'To me, this is the mentality of the Dark Ages.'
The outbreak is primarily centered in Texas, where at least 750 cases have been reported . It's also spread to nearby communities in New Mexico and Kansas. The vast majority of cases have been in unvaccinated people, and the outbreak began in a religious community with a long history of vaccine skepticism.
Three people in connection with the Texas outbreak this year — including 2 children — according to the CDC, and 162 people have been hospitalized. Both children were 'school-age,' according to the Texas Department of Health, and unvaccinated.
Most U.S. states have seen at least one case of measles in 2025.
Yearly measles cases dropped sharply in the 1990s after the CDC's panel of vaccine experts decided to add a second dose of the MMR vaccine to the childhood vaccine schedule. The disease was declared eliminated in the U.S. in 2000 because of widespread immunity through vaccinations, but public health experts have said that, this year, the U.S. is at risk of losing that designation .
— Key context: The 2019 outbreak — like the 2025 Texas outbreak — was tied to close-knit religious communities with a history of vaccine skepticism. But national coverage for the measles, mumps and rubella vaccine has fallen steadily in kindergarteners since the the Covid-19 pandemic — a trend public health experts and officials have said is likely tied to increased vaccine skepticism.
The latest CDC data, for the 2022-2023 school year, found a two percent drop in the vaccination rate among kindergarteners compared to before the pandemic .
Kennedy has shifted on his messaging around the outbreak, sometimes saying that vaccination is the best way to prevent the disease, but at other times inaccurately claiming the shot contains 'aborted fetus debris.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why mRNA Vaccines Are So Revolutionary—And What's at Stake If We Lose Them
Why mRNA Vaccines Are So Revolutionary—And What's at Stake If We Lose Them

Scientific American

time18 minutes ago

  • Scientific American

Why mRNA Vaccines Are So Revolutionary—And What's at Stake If We Lose Them

The U.S. Department of Health and Human Services announced on Tuesday that it will cancel $500 million worth of projects dedicated to designing messenger RNA (mRNA) vaccines for pandemic preparedness. The move drew sharp criticism from medical and health experts. 'Scrapping the fastest platform we have is a reckless move rooted in a fundamental misunderstanding of vaccinology,' wrote Jake Scott, an infectious diseases specialist and clinical associate professor of medicine at Stanford University, on the social media site Bluesky. The use of mRNA in vaccines has opened new doors beyond infectious disease. Researchers are investigating promising mRNA vaccines for pancreatic cancer, which currently has a five-year survival rate of just 13 percent. They're also studying mRNA treatments for multiple other types of cancer, autoimmune disorders and genetic diseases such as sickle cell anemia. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. What makes mRNA so valuable is its programmability—and, for pandemics, the speed at which it can be programmed. Traditional vaccines introduce an inactivated or dead pathogen into the body so that the immune system can learn to recognize and fight it: the immune system stores that memory in case it should ever run across the real thing. Vaccines that use mRNA, on the other hand, instruct the body's own cells to make parts of a protein in or on a pathogen. The body will then learn to recognize this protein without having to fight off the full infectious agent. These vaccines do not interfere with cellular DNA, which is the permanent blueprint, tucked away in the cell nucleus, that tells the cell's machinery what proteins to make. Those proteins, considered the cells' workhorses, then carry out various and critical functions throughout the body. Messenger RNA is a middle step in the process: DNA produces this single-stranded RNA, which then tells the cell how to assemble amino acids into proteins. The mRNA instructions from vaccination degrade within a few days, and studies suggest the spike protein generated by such vaccination against COVID lasts about a month in the body. When making a traditional vaccine, researchers have to manufacture the antigens, or proteins that stimulate the immune system. They might do this by growing a whole virus in bacteria or chicken eggs and then weakening or killing the pathogen with heat or chemicals. In other cases, they use organisms such as yeast that are genetically engineered to churn out pieces of a virus that are familiar to the immune system. In these cases, the manufacturing process takes time, testing and tweaking. For mRNA vaccines, developers design the genetic instructions for an antigen on a computer. The manufacturing process remains the same from vaccine to vaccine, with only the genetic instructions changing. This allows researchers to develop multiple vaccines at once, as well as to develop vaccines that contain mRNA to make multiple antigens for different infections. 'We are working on about 30 different mRNA vaccines, including ones for influenza, HIV, hepatitis C, malaria, tuberculosis, and many others,' said Drew Weissman, a physician-scientist at the Perelman School of Medicine at the University of Pennsylvania, who shared the 2023 Nobel Prize in Physiology or Medicine with biochemist Katalin Karikó for their work on mRNA, in an interview with Nature Medicine in 2021. The loss of HHS funding won't stop all mRNA work in the U.S., but it will stymy research designed to get mRNA vaccines out quickly in a public health emergency. The canceled grants include one to develop an mRNA-based vaccine against H5N1 avian influenza, the strain of bird flu that is currently one of the most salient pandemic threats for people. Researchers who study vaccines had previously warned that current federal officials might target the technology. 'The HHS motivation really is hidden,' said Michael Osterholm, an epidemiologist at the University of Minnesota, to KFF Health News in May, after the Trump administration tightened restrictions on who can access COVID boosters, 'and it's to dismiss all mRNA technology.'

China fights mosquito-borne chikungunya virus with drones, fines and nets as thousands fall ill
China fights mosquito-borne chikungunya virus with drones, fines and nets as thousands fall ill

CNN

time21 minutes ago

  • CNN

China fights mosquito-borne chikungunya virus with drones, fines and nets as thousands fall ill

Chinese authorities are using nets, spraying insecticide and even deploying drones to fight the mosquito-borne chikungunya virus, which has infected thousands of people. Authorities had reported more than 7,000 cases of the virus as of Wednesday, mostly in the southern Chinese manufacturing hub of Foshan, some 170 kilometers (105 miles) from Hong Kong. The number of new cases appears to be dropping slowly, according to authorities. It appears to be the largest chikungunya outbreak ever documented in China, according to Cesar Lopez-Camacho of the University of Oxford. The virus is transmitted by infected mosquitoes and can cause fever and joint pain. 'What makes this event notable is that chikungunya has never been established in mainland China before,' Lopez-Camacho said in a statement. 'This suggests that most of the population had no preexisting immunity, making it easier for the virus to spread quickly.' Chinese state television has shown workers spraying insecticide around city streets, residential areas, construction sites and other areas where people may come into contact with mosquitoes. Workers sprayed some places before entering office buildings. Unusually heavy rains and high temperatures have worsened the crisis in China, and authorities are using drones to try to find standing water, where mosquitoes lay eggs. Authorities also have threatened to fine people who don't empty water from outdoor receptacles. Residents can be subject to fines of up to 10,000 yuan ($1,400) and have their electricity cut off. Because of the virus, the US has issued a travel advisory suggesting that Americans take extra precautions when visiting China's Guangdong province, where Foshan is located, as well as Bolivia and some island nations in the Indian Ocean. Since the 2003 SARS outbreak, China has used strict measures to fight the spread of viruses, including hard-line tactics during the COVID-19 pandemic. This time, patients are being forced to stay in hospital in Foshan for at least one week and authorities briefly enforced a two-week home quarantine, which was dropped because the disease cannot be transmitted between people. Reports also have emerged of attempts to stop the spread of chikungunya with fish that eat mosquito larvae and even larger mosquitoes to eat the insects carrying the virus. Officials have held meetings and adopted protocols at the national level in a sign of China's determination to eliminate the outbreak and avoid public and international criticism.

What to know about mRNA vaccines as Trump admin pulls funding
What to know about mRNA vaccines as Trump admin pulls funding

Axios

timean hour ago

  • Axios

What to know about mRNA vaccines as Trump admin pulls funding

The Trump administration is decreasing funding for the development of mRNA (messenger RNA) vaccines, which were crucial in the response to COVID-19. Why it matters: mRNA vaccines are a public health tool to mitigating future pandemic-like situations, as researchers can move fast at a lower cost than other vaccine systems. "mRNA vaccines use a genetic code to tell the body's cells to produce proteins that train the immune system," a Penn Medicine report said. "The result: 'plug-and-play' vaccines with rapid development times and lower costs." Driving the news: Health Secretary Robert F. Kennedy Jr. said Tuesday that the government would pull $500 million in mRNA vaccine development funding in order to focus on "safer, broader vaccine platforms." No new mRNA based projects will be initiated, HHS said. Some final-stage contracts for targets like pandemic bird flu will run their course. What they're saying: " I've tried to be objective & non-alarmist in response to current HHS actions — but quite frankly this move is going to cost lives," Jerome Adams, who served as surgeon general during President Trump's first administration, said on X. "It's rhetoric of wellness ideologues who deny the benefits of mRNA vaccine technology in saving 3.2 million American lives in the pandemic," Peter Hotez, Baylor College of Medicine vaccine researcher, said on X. "Also in my view it's [a] slap in the face for President Trump, given this is one of his best achievements." What are mRNA vaccines? How do they work? The big picture: mRNA vaccines use a molecule necessary for protein production, called messenger RNA, rather than part of an actual bacteria or virus, according to the National Library of Medicine. mRNA vaccines introduce a piece of mRNA that corresponds to a viral protein, prompting cells to produce the viral protein. People who get an mRNA vaccine are not exposed to the virus, nor can they become infected with a virus by the vaccine. Flashback: mRNA was discovered in the early 1960s, and research into how it could be delivered into cells was developed in the 1970s, per Johns Hopkins ' Bloomberg School of Public Health. The intrigue: The biggest challenge with mRNA was that it was taken up by the body and quickly degraded before it could "deliver" the RNA transcript and be read into proteins in the cells. Advances in nanotechnology allowed for fatty droplets, or lipid nanoparticles, to wrap the mRNA like a bubble and allowed entry into the cells. Didn't the COVID vaccine use mRNA? State of play: The Pfizer-BioNTech and Moderna COVID vaccines use mRNA. "Thanks to decades of research and innovation, mRNA vaccine technology was ready," the Johns Hopkins report said. "With COVID, this technology got its moment and has proven to be extremely safe and effective." Context: The COVID-19 mRNA vaccine gives cells instructions for how to make the S protein found on the surface of the virus, according to Mayo Clinic. The body creates antibodies that help clear the virus, if caught. What else could mRNA vaccines help protect against? Zoom out: Researchers at Penn Medicine are developing mRNA vaccines for infections including avian bird flu, all coronaviruses such as SARS and MERS, C. difficile, genital herpes, hepatitis C, HIV, influenza, leptospirosis, malaria, norovirus and tuberculosis. Moderna has mRNA vaccines in various levels of development to fend against RSV, HIV, Lyme disease, Mpox, several cancers and cystic fibrosis. What we're watching: As of January, more than 120 clinical trials were testing the potential for mRNA vaccines in cancer treatment across various malignancies, according to research published in the National Library of Medicine.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store